These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33520957)

  • 1. Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles.
    Lokras A; Thakur A; Wadhwa A; Thanki K; Franzyk H; Foged C
    Front Bioeng Biotechnol; 2020; 8():601155. PubMed ID: 33520957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
    Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
    Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
    Lokras A; Foged C; Thakur A
    Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
    Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
    Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a Quality-By-Design Approach to Optimise Lipid-Polymer Hybrid Nanoparticles Loaded with a Splice-Correction Antisense Oligonucleotide: Maximising Loading and Intracellular Delivery.
    Thanki K; Papai S; Lokras A; Rose F; Falkenberg E; Franzyk H; Foged C
    Pharm Res; 2019 Jan; 36(3):37. PubMed ID: 30623253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
    Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
    J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Factors of Importance for Spray Drying of Small Interfering RNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles for Inhalation.
    Dormenval C; Lokras A; Cano-Garcia G; Wadhwa A; Thanki K; Rose F; Thakur A; Franzyk H; Foged C
    Pharm Res; 2019 Aug; 36(10):142. PubMed ID: 31376020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, Characterization, and In Vitro Evaluation of Lipidoid-Polymer Hybrid Nanoparticles for siRNA Delivery to the Cytosol.
    Thanki K; Zeng X; Foged C
    Methods Mol Biol; 2019; 1943():141-152. PubMed ID: 30838614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering of budesonide-loaded lipid-polymer hybrid nanoparticles using a quality-by-design approach.
    Leng D; Thanki K; Fattal E; Foged C; Yang M
    Int J Pharm; 2018 Sep; 548(2):740-746. PubMed ID: 28847667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing TNFα with lipidoid nanoparticles downregulates both TNFα and MCP-1 in an in vitro co-culture model of diabetic foot ulcers.
    Kasiewicz LN; Whitehead KA
    Acta Biomater; 2016 Mar; 32():120-128. PubMed ID: 26689461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(lactide-
    Wu L; Wu LP; Wu J; Sun J; He Z; Rodríguez-Rodríguez C; Saatchi K; Dailey LA; Häfeli UO; Cun D; Yang M
    ACS Appl Mater Interfaces; 2021 Jan; 13(3):3722-3737. PubMed ID: 33439616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model.
    Bohr A; Tsapis N; Foged C; Andreana I; Yang M; Fattal E
    Eur J Pharm Biopharm; 2020 Nov; 156():114-120. PubMed ID: 32798665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of polymeric siRNA nanocarriers in a murine LPS-activated macrophage cell line: gene silencing, toxicity and off-target gene expression.
    Jensen LB; Griger J; Naeye B; Varkouhi AK; Raemdonck K; Schiffelers R; Lammers T; Storm G; de Smedt SC; Sproat BS; Nielsen HM; Foged C
    Pharm Res; 2012 Mar; 29(3):669-82. PubMed ID: 21971827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy.
    Xiao B; Laroui H; Ayyadurai S; Viennois E; Charania MA; Zhang Y; Merlin D
    Biomaterials; 2013 Oct; 34(30):7471-82. PubMed ID: 23820013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
    Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
    Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
    He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C
    Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design.
    de Groot AM; Thanki K; Gangloff M; Falkenberg E; Zeng X; van Bijnen DCJ; van Eden W; Franzyk H; Nielsen HM; Broere F; Gay NJ; Foged C; Sijts AJAM
    Mol Ther Nucleic Acids; 2018 Jun; 11():159-169. PubMed ID: 29858051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidating the nanostructure of small interfering RNA-loaded lipidoid-polymer hybrid nanoparticles.
    Aljabbari A; Lokras AG; Kirkensgaard JJK; Rades T; Franzyk H; Thakur A; Zhang Y; Foged C
    J Colloid Interface Sci; 2023 Mar; 633():907-922. PubMed ID: 36508398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
    Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
    J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.